Medsir

This study tested a drug called HER3-DXd in 63 adults with breast cancer, lung cancer, or other solid tumors that had spread to the brain or the lining around the brain and spinal cord. The goal was to see if the drug could shrink brain tumors or help patients live longer. Partic…

This study tested a combination of two drugs, pembrolizumab and lenvatinib, in 43 people with advanced thymic carcinoma or a related thymoma that had worsened after standard chemotherapy. The goal was to see if the combination could stop or slow cancer growth. Participants receiv…

This study tested two treatment plans for people with advanced HR+/HER2- breast cancer that is aggressive. One group got a drug called abemaciclib plus hormone therapy, while the other group started with chemo followed by the same combo. The goal was to see which approach works b…

This study tested two hormone therapies, giredestrant and tamoxifen, in 92 premenopausal women with early-stage breast cancer. Participants took the drug for 15 days before surgery to see how well it slowed tumor growth. The goal was to compare the drugs' effects on cancer cell a…

This study tested whether adding two supportive drugs (loperamide for diarrhea and G-CSF for low white blood cells) could reduce severe side effects of the cancer drug sacituzumab govitecan. It involved 50 adults with advanced triple-negative or luminal breast cancer that had spr…